MRSH
Marsh & McLennan Companies, Inc. NYSE$167.87
Mkt Cap $80.9B
52w Low $164.89
4.2% of range
52w High $235.78
50d MA $175.38
200d MA $187.77
P/E (TTM)
19.6x
EV/EBITDA
14.8x
P/B
5.3x
Debt/Equity
1.4x
ROE
-100.0%
P/FCF
18.1x
RSI (14)
—
ATR (14)
—
Beta
0.75
50d MA
$175.38
200d MA
$187.77
Avg Volume
3.2M
About
Marsh & McLennan Cos., Inc. is a professional services firm, which offers clients advice and solutions in risk, strategy and people. The company is headquartered in New York, New York and currently employs 65,000 full-time employees. The firm is the parent company of various risk advisors and specialty consultants, including Marsh, the insurance broker; Guy Carpenter, the risk and reinsurance spec…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | AMC | 3.22 | 3.29 | +2.2% | 182.57 | -0.4% | -3.7% | -4.4% | -2.0% | -3.9% | -4.7% | — |
| Jan 29, 2026 | AMC | 1.97 | 2.12 | +7.6% | 187.92 | +1.1% | +0.1% | +0.2% | +0.3% | +1.0% | -0.2% | — |
| Oct 16, 2025 | AMC | 1.78 | 1.85 | +3.9% | 186.48 | +0.2% | +1.7% | +1.8% | +1.3% | +1.5% | +0.9% | — |
| Jul 17, 2025 | AMC | 2.67 | 2.72 | +1.9% | 211.04 | +0.0% | +0.6% | -0.5% | -0.4% | -0.6% | -1.3% | — |
| Apr 17, 2025 | AMC | 3.02 | 3.06 | +1.3% | 220.07 | -0.7% | -3.6% | -0.2% | -0.5% | -0.5% | -0.4% | — |
| Jan 30, 2025 | AMC | 1.76 | 1.87 | +6.2% | 220.83 | -0.8% | -1.8% | -0.7% | +1.0% | +2.1% | +2.3% | — |
| Oct 17, 2024 | AMC | 1.61 | 1.63 | +1.2% | 226.92 | +1.1% | -1.0% | -2.1% | -2.2% | -1.5% | -2.0% | — |
| Jul 18, 2024 | AMC | 2.40 | 2.41 | +0.4% | 217.42 | +1.0% | -0.3% | +0.7% | +0.7% | +0.0% | -0.6% | — |
| Apr 18, 2024 | AMC | 2.80 | 2.89 | +3.2% | 201.73 | +0.4% | +0.3% | -0.1% | -0.0% | -0.4% | -0.1% | — |
| Jan 25, 2024 | AMC | 1.63 | 1.68 | +3.1% | 191.09 | -0.3% | +1.0% | -0.1% | +1.0% | +1.4% | +1.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $182.57 | $181.76 | -0.4% | -3.7% | -4.4% | -2.0% | -3.9% | -4.7% |
| Apr 14 | BofA Securities | Maintains | Underperform → Underperform | — | $173.55 | $172.49 | -0.6% | -0.4% | +0.8% | +5.2% | +1.3% | +0.6% |
| Apr 13 | Mizuho | Maintains | Neutral → Neutral | — | $168.15 | $168.83 | +0.4% | +3.2% | +2.8% | +4.0% | +8.6% | +4.5% |
| Apr 9 | JP Morgan | Maintains | Overweight → Overweight | — | $175.81 | $173.36 | -1.4% | -1.5% | -4.4% | -1.3% | -1.7% | -0.5% |
| Apr 9 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $175.81 | $173.36 | -1.4% | -1.5% | -4.4% | -1.3% | -1.7% | -0.5% |
| Apr 8 | Barclays | Maintains | Overweight → Overweight | — | $172.66 | $171.99 | -0.4% | +1.8% | +0.3% | -2.6% | +0.5% | +0.1% |
| Apr 7 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $174.82 | $175.18 | +0.2% | -1.2% | +0.6% | -1.0% | -3.8% | -0.7% |
| Apr 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $174.61 | $175.00 | +0.2% | +0.1% | -1.1% | +0.7% | -0.8% | -3.7% |
| Mar 11 | Barclays | Maintains | Overweight → Overweight | — | $174.00 | $174.35 | +0.2% | -0.0% | -1.8% | -1.1% | -0.1% | -1.2% |
| Feb 27 | Mizuho | Downgrade | Outperform → Neutral | — | $185.29 | $185.45 | +0.1% | +0.8% | +0.6% | -0.6% | -0.2% | -0.2% |
Recent Filings
8-K
Unknown — 8-K Filing
Marsh's 8% adjusted EPS growth to $3.29 signals strong operational efficiency and profitability momentum, justifying confidence in management's ability to navigate market challenges and potentially supporting stock valuation.
Apr 16
8-K
Unknown — 8-K Filing
Marsh McLennan issued a press release on April 14, 2026, likely announcing quarterly earnings or significant company developments that investors should review to assess business performance and strategic direction.
Apr 14
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A newly hired executive at Marsh receives a $1.75M long-term incentive package starting 2027, signaling management confidence but creating near-term dilution and potential overpayment risk that investors should evaluate against operational improvements.
Mar 10
8-K · 5.02
!!! Very High
Marsh -- 8-K 5.02: Executive Change
Peter Harrison's appointment as director at Marsh strengthens board oversight and may signal the company's commitment to strengthening governance as it navigates evolving insurance market challenges.
Feb 25
8-K
Marsh -- 8-K Filing
Marsh has issued convertible notes, with the terms and form of the securities detailed in exhibits, providing the company with additional capital financing options.
Feb 19
Data updated apr 26, 2026 1:17pm
· Source: massive.com